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Background: The derivatives of thieno[2,3-b]thiophene belong to a significant category of heterocyclic
compounds, which have shown a wide spectrum of medical and industrial application.
Results: A new building block with two electrophilic center of thieno[2,3-b]thiophene derivatives 2 has been reported
by one-pot reaction of diketone derivative 1 with Br2/AcOH in excellent yield. A variety of heteroaromatics having bis
(1H-imidazo[1,2a] benzimidazole), bis(1H-imidazo[1,2-b][1,2,4]triazole)-3-methyl-4-phenylthieno[2,3-b]thiophene
derivatives, dioxazolo-, dithiazolo-, and 1H-imidazolo-3-methyl-4-phenylthieno[2,3-b]thiophene derivatives as well
pyrrolo, thiazolo −3-methyl-4-phenylthieno[2,3-b]thiophene derivatives have been designed, synthesized, characterized,
and evaluated for their biological activity. Compounds 3–9 showed good bioassay result. These new derivatives were
evaluated for anti-cancer activity against PC-3 cell lines, in vitro antioxidant potential and β-glucuronidase and
α-glucosidase inhibitory activities. Compound 3 (IC50 = 56.26 ± 3.18 μM) showed a potent DPPH radical scavenging
antioxidant activity and found to be more active than standard N-acetylcystein (IC50 = 105.9 ± 1.1 μM). Compounds
8a (IC50 = 13.2 ± 0.34 μM) and 8b (IC50 = 14.1 ± 0.28 μM) found as potent inhibitor of α-glucusidase several fold more
active than the standard acarbose (IC50 = 841 ± 1.73 μM). Most promising results were obtained in β-glucuronidase
enzyme inhibition assay. Compounds 5 (IC50 = 0.13 ± 0.019 μM), 6 (IC50 = 19.9 ± 0.285 μM), 8a (IC50 = 1.2 ± 0.0785 μM) and
9 (IC50 = 0.003 ± 0.09 μM) showed a potent inhibition of β-glucuronidase. Compound 9 was found to be several hundred
fold more active than standard D-Saccharic acid 1,4-lactone (IC50 = 45.75 ± 2.16 μM).
Conclusions: Synthesis, characterization, and in vitro biological activity of a series of thieno[2,3-b]thiophene have been
investigated.
Keywords: Thienothiophene, Oxazole, Imidazole, Thiazole, Bisheterocycles, β-glucuronidase inhibition, α-glucosidase
inhibition, DPPH radical scavenging activity, Ctotoxicity, Cancer cell lineBackground
Thieno[2,3-b]thiophenes represent a class of heterocyclic
compounds endowed with potent antitumor and antiviral
activity,[1-7] In particular, thienothiophene derivatives are
reported as antiglaucoma drugs, as inhibitors of platelet
aggregation, or as antibitotic [8-12]. Annulation of hetero-
cyclic moieties on the thieno[2,3-b]thiophene nucleus led* Correspondence: yahia@ksu.edu.sa; ambarakat@ksu.edu.sa
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distribution, and reproduction in any mediumto the formation of diverse hetero analogues, which
exhibited remarkable chemical and biological activities.
For the past few years, Various protocols have been pre-
pared and evaluated biologically important compounds
derived from thieno [2,3-b]thiophene [13-28]. We have
reported for the first time the anti-cancer, anti-oxidant
and β-glucuronidase and α-glucosidase inhibition poten-
tial of thieno[2,3-b]thiophenes based molecules [20].
Furthermore, Studies revealed that compounds with
nitrogen-oxygen- and sulfur containing heterocycles are
chemotherapeutics available. Thiazoles and their deriva-
tives have attracted much attention due to their widentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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treat allergies, [29] schizophrenia, hypertension, inflam-
mation, bacterial and HIV infections [30-35].
The promising results of previous studies [20,36-38]
prompted us to further extend our research towards the
synthesis of annulation of heterocyclic systems of poten-
tial biological application. In continuation of our previ-
ous work we are reporting here the synthesis of some
more analogues of thieno[2,3-b]thiophene moiety as a
base unit and their in vitro anti-oxidant activity, includ-
ing α-glucosidase and β-glucuronidase inhibition and an-
ticancer activity against PC-3 cell lines.
Results and discussion
Chemistry
One possible synthetic strategy for the target bis(1H-
imidazo[1,2a] benzimidazole) and bis(1H-imidazo[1,2-b]
[1,2,4]triazole)-3-methyl-4-phenylthieno[2,3-b]thiophene
derivatives, dioxazolo-, dithiazolo-, and 1H-imidazolo-3-
methyl-4-phenylthieno[2,3-b]thiophene derivatives as well
pyrrolo, thiazolo-3-methyl-4-phenylthieno[2,3-b]thiophene
derivatives as could have made use of bromoketone 2
(Scheme 1) as template for the annulation of the five mem-
ber ring. Such intermediates were obtained from ketone of
type 1, about which not much is reported in literature.
Having in hand a new building block of starting ketones
of type 1, the next step would be the functionalization of a
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Scheme 1 Synthesis of 2, 3, and 4a-c.second electrophilic center that, together with the
carbonyl group, should allow the cyclization with
dinucleophiles. Direct introduction of the bromine
functionality was also studied.
Thieno[2,3-b]thiophene derivatives 1 was converted
into the corresponding bromoketone2 (85%) using Br2
in refluxing AcOH for 1 h. The desired product was
obtained by filtration, washed with water, dried well and
recrystallized from ethanol to give white crystals.
To synthesize the bis heterocyclic system, we could
react bromoketone 2 with 1,3-dinucleophiles having a
C-C-N structure, such as cyanothioacetamide, 2-cyano-
2-arylmethylene-thioacetamide, and malononitrile.
Compound 3 was synthesized by reaction of bromoketone
2 with suitably cyanothioacetamide under conventional re-
flux conditions in the presence of a catalytic amount of TEA
using ethanol as a solvent. The structure of the isolated
cycloadduct was determined by IR, 1H NMR, 13C NMR,
mass spectral and elemental analyses. The utility of 3
towards suitably aldehydes for example benzaldehyde,
p-chlorobenzaldehyde, p-methoxybenzaldehyde was also
investigated. Compounds 4a-c were prepared by reaction
of 3 with suitable aromatic aldehyde under conventional
reflux conditions in the presence of a catalytic amount of
TEA using ethanol as a solvent. Alternatively, compounds
4a-c were obtained by the fusion of thieno[2,3-b]
thiophene derivative 2 with 2-cyano-2-arylmethylene-
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sponding bromoketone 2 with malononitrile by ther-
mal intramolecular cyclization reaction via an initial
Michael type adduct. The IR(KBr) spectrum of compound
5, exhibit absorption band due to the stretching vibrations
of CN group at 2212 cm−1. The later compound was also
confirmed by 1H-NMR spectrum exhibited signals at δ
1.20, 1.90, and 3.90, due to CH3, CH2, and CH pyrrole
protons respectively, in addition to an aromatic multiplet
in the region of δ 7.53–7.57. Its mass spectrum showed
the molecular ion peak at m/z 410 (see Additional file 1).
Annulated heterocycles was further developed via reac-
tion of bromoketone2 with different nucleophiles likes 2-
aminobenzimidazole, 4-amino-1,2,4-triazole with a view
to synthesizing various heterocyclic ring systems. Com-
pounds 6–7 were synthesized by reaction of 2 with
suitably amine derivatives under conventional reflux
conditions in the presence of a catalytic amount of
TEA using ethanol as a solvent affording the desired
product 6 (87%) and 7 (72%)(Scheme 2). The 1H-NMR
(DMSO-d6) spectrum of the compound 6 revealed
three singlets signal at δ 1.96, 8.86, and 12.82 assigned
to CH3, CH (imidazo-H), and NH (hydrogen-bonded
with S) respectively. Its mass spectrum revealed a mo-
lecular ion peak at m/z 540. It is assumed that the
product 7 was formed via initial formation of a
nonisolable hydrazonal followed by elimination of H2O
and HBr to give the desired product.
Addition experiments of bromoketone 2 were carried
out to afford the oxazole, thiazole, and 1H-imidazole
after an elimination/aromatization of the cycloadduct
intermediate. Conventional heating of bromoketone 2
with the corresponding N-nucleophile urea derivatives
derivative at reflux temperatures had to be employed for
the synthesis of oxazole, thiazole, and 1H-imidazole de-
rivatives 8a-c were synthesized following the conven-
tional procedure bromoketone 2 with in ethanol at
reflux in very good yield as depicted in (Scheme 3).
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Scheme 2 Synthesis of annulated heterocycles 6,7.stepwise formation of hydrazone followed by a Michael
1,4-addition of the nucleophile nitrogen atom.
The structure of the desired compound 8a was de-
duced by the 1H-NMR (DMSO-d6) spectrum which
displayed a three singlet’s signal at δ 1.79, 6.76, and 7.54
assignable to CH3, NH2, and CH of oxazole ring respect-
ively. The formation of compound 8a would involve an
initial addition of the amino group in urea to the elec-
trophilic center of bromo functionalities in bromoketone
2, then elimination of HBr subsequently cyclization
and aromatization via loss of water gave the final de-
sired compound (Scheme 3). The later hypothesis has
been confirmed by reaction only bromoketone 2
(dielectrophilic centers) with only one nucleophilic
center such as amine derivatives. Thus refluxing
bromoketone 2 with aniline derivatives in EtOH for 6-8 h
affording 9a-b in excellent yield (Scheme 3). Spectral data
(IR, NMR, MS) and elemental analysis were consistent
with isolated product 9a. The 1H-NMR spectrum of 9a
showed three singlets signal at δ 2.02, 4.42 and 7.61 due to
CH3, CH2, and NH protons, in addition IR spectrum re-
vealed absorption band at 1653, and 3385 cm−1 corre-
sponding to two C =O and amino functions, respectively.
Its mass spectrum revealed a molecular ion peak at m/z
496 it means that doesn’t contain a Br atom.
Biological activity evaluation
Compounds 3–9 were evaluated for potential biological
activities through a battery of in vitro biochemical assays
including anticancer activity against PC-3 cell lines, anti-
oxidant potential in DPPH radical scavenging assay and
β-glucuronidase and α-glucosidase enzyme inhibition as-
says. The results are presented in Table 1.
Compound 3 (IC50 = 1.3 ± 0.172 μM) showed a po-
tent antioxidant potential in DPPH radical scavenging
assay and found to be more active than the standard
N-acetylcystein (IC50 = 105.9 ± 1.1 μM). All other
compounds found to be inactive. Compounds 5 (IC50 =
0.13 ± 0.019 μM), 6 (IC50 = 19.9 ± 0.285 μM), 8ae
O
Br
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8a, X = O
8b, X = S
8c, X = NH
9a, Y = H
9b, Y = Cl
Scheme 3 Synthesis of 8a–c and 9a-b.
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http://journal.chemistrycentral.com/content/7/1/112(IC50 = 1.2 ± 0.0785 μM) and 9 (IC50 = 0.003 ± 0.09
μM) showed promising results for β-glucuronidase in-
hibition activity and found to be several fold more ac-
tive than the standard D-Saccharic acid 1,4-lactone
(IC50 = 45.75 ± 2.16 μM). 2-Aminoxazole and 2-
aminothiazole substituted bis-thiazole ring containing
compounds 8a (IC50 = 13.2 ± 0.34 μM) and 8b (IC50 =
14.1 ± 0.28 μM) showed potent α-glucosidase enzyme
inhibition. Compound 8b also found as moderate anti-
cancer agent (IC50 = 24.213 ± 0.29 μM) against PC-3
cell lines while tested against standard drug doxorubicin
(IC50 = 0.912 ± 0.12 μM) as. All other compounds (3-8a, 9)
were found to be non cytotoxic and showed >30% inhib-














8b 24.213 ± 0.29 -
9a >30 NA
9b >30 NA
Std. Doxorubicin 0.91 ± 0.1 N-Acetylcysteine 106 ± 1.1
SEM = standard error of mean.
NA = not active; failed to show 50% or more inhibition at 500 μM or more.Conclusions
In conclusion, we have successfully developed an easy
practical access to novel and readily accessible building
block 2 for the synthesis of biologically important com-
pounds incorporating thieno[2,3-b]thiophene core (3–9).
These compounds were evaluated for their biological ac-
tivities in various in vitro biological assays. The potent
antioxidant and α-glucosidase inhibiting activities of
compounds 3 and 8a, respectively, indicates their poten-
tial as possible leads for the treatment of oxidative stress
and hyperglycemia associated health disorders. The most
promising results of β -glucuronidase enzyme inhibitors
5, 6, 8a and 9 can serve as templates for the new drug
candidates for the treatment of cancer, rheumatoid9








0.130 ± 0.019 -
19.9 ± 0.285 -
1.2 ± 0.0785 -
NA -
1.2 ± 0.0785 13.2 ± 0.34
NA 14.1 ± 0.28
0.003 ± 0.09 NA
NA -
D-Saccharic acid 1,4- lactone 45.75 ± 2.16 Acarbose 841 ± 1.7
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http://journal.chemistrycentral.com/content/7/1/112arthritis, AIDS and other health problems associated
with over expression of β -glucuronidase enzyme.
Experimental section
General
All melting points were measured on a Gallenkamp
melting point apparatus. IR spectra were measured as
KBr pellets on a Perking Elmer FT 1000 spectrophotom-
eter. The NMR spectra were recorded on a Varian Mer-
cury Jeol-400 NMR spectrometer. 1H-NMR (400 MHz)
and 13C-NMR were run in dimethylsulphoxide (DMSO-
d6). Chemical shifts (δ) are referred in terms of ppm and
J -coupling constants are given in Hz. Abbreviations for
multiplicity is as follows: s (singulet), d (doublet), t (trip-
let), q (quadruplet), m (multiplet). Mass spectra were
recorded on a Shimadzu GCMS-QP 1000 EX mass spec-
trometer at 70 eV. Elemental analysis was carried out on
an Elementar Vario EL analyzer.
1,1'-(3-Methyl-4-phenylthieno[2,3-b]thiophene-2,5-diyl)bis
(2-bromoethanone) (2)
A mixture of 1 (3.14 g, 10 mmol) in glacial acetic acid
(100 mL). The reaction mixture was heated up to 80–90°C
with vigorous stirring. To this hot solution, bromine
(1.1 mL) in glacial acetic acid (20 mL) was added drop wise
over a period of 30 min. After complete addition of brom-
ine, the reaction mixture was stirred vigorously at room
temperature for further 1 h till the release of hydrogen
bromide gas ceased, then poured onto ice. The solid product
was collected by filtration, washed with water, dried well and
recrystallized from ethanol to give white crystals of 2; Yield:
85%; solid, mp 142–144°C;IR (KBr) νmax/ cm
−1: 1653;
1H-NMR (400 MHz, DMSO-d6)δ 1.95 (s, 3H, CH3)
4.73 (s, 4H, 2CH2), 7.52-7.58 (m, 5H, Ar-H);
13C-NMR
(100 MHz, DMSO-d6)δ 185.2, 160.8, 149.7, 141.2,
137.9, 135.9, 133.3, 129.2, 128.5, 125.5, 35.5, 13.8; MS m/z
(%): 472 [M+, 35%]; Anal. calcd. for C17H12Br2O2S2 : C,
43.24; H, 2.56; S, 13.58; Found:C,43.19; H, 2.58; S,13.21.
2,2'-(4,4'-(3-Methyl-4-phenylthieno[2,3-b]thiophene-2,
5-diyl)bis(thiazole-4,2-diyl)) diacetonitrile (3)
A mixture of compound 2 (472 mg, 1 mmol) and 2-
cyanoethanethioamide (200 mg, 2 mmol) was heated
under reflux for 8 h in EtOH (15 mL), in the presence of
0.5 mL of (TEA). The solid product was collected by fil-
tration to give dark brown powder crystals; Yield (72%);
solid, mp > 320°C; IR (KBr) νmax/ cm
−1: 2247 ; 1H-NMR
(400 MHz, DMSO-d6)δ 1.84 (s, 3H, CH3), 3.45 (s, 4H,
2CH2), 6.3 (s, 2H, 2CH), 7.43-7.70 (m, 5H, Ar-H);
13C-
NMR (100 MHz, DMSO-d6)δ 158.5, 158.2, 147.9, 147.7,
146.7, 135.0, 129.3, 128.9, 128.3, 127.3, 116.6, 115.8,
21.2, 13.4; MS m/z(%): 474[M+, 4%]; Anal. calcd. for
C23H14N4S4: C, 58.20; H, 2.97; N, 11.80; S, 27.02; Found:
C, 59.10; H, 2.86; N, 11.91; S, 26.12.Compounds 4a-c was prepared in two methods
Method A (GP1)
Fusion of compound 2 (236 mg, 0.5 mmol) with 2-cyano-
3-arylprop-2-enethioamide derivatives (2 equiv., 1 mmol).
The solid product was collected by filtration and washed
with EtOH, dried and the crude product was recrystallized
from EtOH / DMF to give the corresponding compounds
(4a-c).
Method A (GP2)
A mixture of compound 3 (237 mg, 0.5 mmol) and aro-
matic aldehydes (2 equiv., 1 mmol) was refluxed in
EtOH (15 mL) for 7–9 h in the presence of 0.5 mL of
(DMF). The solid product was collected by filtration to




4a was prepared from 2-cyano-3-phenylprop-2-enethioamide
following GP1, and from benzaldehyde following GP2, as
a pale brown powder crystals; Yield (88%GP1,79% GP2);
solid, mp 220–221°C; IR (KBr) νmax/ cm
−1: 1606, 2212;
1H-NMR (400 MHz, DMSO-d6)δ 1.93 (s, 3H, CH3), 7.49-
8.03 (m, 15H, Ar-H) 8.21 (s, 2H, 2CH), 8.30 (s, 2H, 2Ar-
CH); 13C-NMR (100 MHz, DMSO-d6)δ 162.8, 146.1,
140.3,137.7, 136.4, 135.4, 133.5, 132.8, 130.2, 129.9, 129.1,
128.6, 125.4, 116.5, 115.8, 113.0, 14.3: MS m/z(%): 650
[M+, 1.5%]; Anal. calcd. for C37H22N4S4: C, 68.28; H,





4b was prepared from 2-cyano-3-(4-chlorophenyl)prop-2-
enethioamide following GP1, and from 4-chlorobenzaldehyde
following GP2, as a pale brown powder crystals; Yield
(84%GP1 , 80% GP2); solid, mp 167–168°C;IR (KBr) νmax/
cm−1: 1606, 2218; 1H-NMR (400 MHz, DMSO-d6)δ 1.97
(s, 3H, CH3), 7.48-8.05 (m, 15H, Ar-H) 8.16 (s, 2H, 2CH),
8.28 (s, 2H, 2Ar-CH); 13C-NMR (100 MHz, DMSO-d6)δ
162.8, 146.1, 139.8,137.2, 136.1, 135.1, 133.5, 130.2, 129.9,
129.1, 128.6, 127.2, 116.5, 115.8, 112.0, 14.3; MS m/z(%):
719[M+, 1.5%]; Anal. calcd. for C37H20Cl2N4S4: C, 61.74;





4c was prepared from 2-cyano-3-(4-methoxyphenyl)
prop-2-enethioamide following GP1, and from 4-
methoxybenzaldehyde following GP2, as a pale brown
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238–239°C; IR (KBr) νmax/ cm
−1: 1606, 2212;1H-NMR
(400 MHz, DMSO-d6)δ 1.96 (s, 3H, CH3), 3.85 (s, 3H,
O-CH3), 7.14-8.01 (m, 15H, Ar-H), 8.23 (s, 2H, 2CH),
8.31 (s, 2H, 2Ar-CH); 13C-NMR (100 MHz, DMSO-
d6)δ 162.8, 146.1, 140.3,138.9, 137.0, 135.9, 134.8,
132.3, 130.2, 129.9, 129.1, 128.6, 116.5, 115.7, 55.8,
14.3; MS m/z(%): 710[M+, 1.5%]; Anal. calcd. for
C39H26N4O2S4: C, 65.89; H, 3.69; N, 7.88; S, 18.04;
Found: C, 66.76; H, 3.59; N, 7.97; S, 18.74.
3-(5-(4-Cyano-2H-pyrrol-3-yl)-3-methyl-4-phenylthieno
[2,3-b]thiophen-2-yl)-2H-pyrrole-4-carbonitrile (5)
A mixture of compound 2 (472 mg, 1 mmol) and
malononitrile (132 mg, 2 mmol) was heated under reflux
for 8 h in EtOH (15 mL), in the presence of 0.5 mL of
(TEA). The solid product was collected by filtration to give
dark purple powder crystals; Yield (66%); solid, mp >
320°C; IR (KBr) νmax/ cm
−1: 2212;1H-NMR (400 MHz,
DMSO-d6) δ 1.2 (s, 4H, 2CH2), 1.9 (s, 3H, CH3), 3.9 (s, 2H,
2CH), 7.53-7.57 (m, 5H, Ar-H); 13C-NMR (100 MHz,
DMSO-d6)δ 159.6, 142.8, 138.7, 137.6, 135.0, 129.7, 129.3,
128.9, 128.3, 127.3, 115.8, 94.2, 55.9,13.4; MS m/z(%): 410
[M+, 36%]; Anal. calcd. for C23H14N4S2: C, 67.29; H, 3.44;




A mixture of compound 2 (236 mg, 0.5 mmol) and 2-
aminobenzimidazole (133 mg, 1 mmol) was refluxed in
EtOH (15 mL) for 10 h in the presence of 0.5 mL of tri-
ethyl amine (TEA). The resulting solid product was col-
lected by filtration to give a reddish brown crystals;
Yield (87%); solid, mp > 320°C; IR (KBr) νmax/ cm
−1:
3373;1H-NMR (400 MHz, DMSO-d6)δ 1.96 (s, 3H,
CH3), 7.37-7.25 (m, 13H, Ar-H), 8.86 (s, 2H, 2CH
imidazo-H), 12.82 (s, 2H, 2NH); 13C-NMR (100 MHz,
DMSO-d6)δ 157.2, 148.2, 147.6, 141.4, 138.5, 134.2,
129.2, 128.8, 125.0, 124.9, 124.5, 112.5, 1007.1, 15.8; MS
m/z(%): 540[M+, 57%]; Anal. calcd. for C31H20N6S2: C,
68.87; H, 3.73; N, 15.54; S, 11.86; Found: C, 68.79; H,
3.76; N, 15.53; S, 11.89.
5,5'-(3-Methyl-4-phenylthieno[2,3-b]thiophene-2,5-diyl)bis
(1H-imidazo[1,2-b] [1,2,4]triazole) (7)
A mixture of compound 2 (236 mg, 0.5 mmol) and 3-
amino-1H-1,2,4-triazole (84 mg, 1 mmol) was heated
under reflux for 8 h in EtOH (10 mL) in the presence of
0.5 mL of (TEA). The solid product was collected by fil-
tration to give brown crystals; Yield (79%); solid, mp >
320°C; IR (KBr) νmax/ cm
−1: 3410;1H-NMR (400 MHz,
DMSO-d6)δ 1.92 (s, 3H, CH3), 7.52-7.42 (m, 5H, Ar-H),
8.52 (s, 2H, 2CH), 9.86 (s, 2H, 2 N = CH), 12.41 (s, 1H,NH); 13C-NMR (100 MHz, DMSO-d6) δ 163.0, 156.5,
148.4,144.4, 140.9, 137.8, 129.7, 124.0, 120.1, 15.4;MS
m/z(%): 442[M+, 46%]; Anal. calcd. for C21H14N8S2: C,
57.00; H, 3.19; N, 25.32; S, 14.49; Found: C, 56.91; H,
3.22; N, 25.12; S, 14.59.
General procedure for the synthesis of compounds 8a-c
(GP3)
A mixture of compound 2 (0.472 g, 1 mmol), and urea
derivatives (2 equiv., 2 mmol) was refluxed in EtOH
(15 mL) for 6–8 h in the presence of 0.5 mL of (TEA).




8a was prepared from urea following GP3 as a brown
powder crystals; Yield (73%); solid, mp > 320°C;IR (KBr)
νmax/ cm
−1: 1622, 3441;1H-NMR (400 MHz, DMSO-d6)δ
1.79 (s, 3H, CH3), 6.76 (s, 4H, 2NH2), 7.38-7.53 (m, 5H,
Ar-H), 7.54 (s, 2H, 2CH); 13C-NMR (100 MHz, DMSO-
d6)δ 159.3, 148.8, 148.1, 136.0, 134.3, 129.8,14.8; MS m/z
(%): 394[M+, 2%]; Anal. calcd. for C19H14N4O2S2: C,
57.85; H, 3.58; N, 14.20; O, 8.11; S, 16.26; Found: C,
57.74; H, 3.52; N, 14.32; S, 16.34.
4,4'-(3-Methyl-4-phenylthieno[2,3-b]thiophene-2,5-diyl)
dithiazol-2-amine (8b)
8b was prepared from thiourea following GP3 as a dark
green powder crystals; Yield (75%); solid, mp 260–261°C;
IR (KBr)νmax/ cm
−1: 1620, 3439; 1H-NMR (400 MHz,
DMSO-d6)δ 1.76 (s, 3H, CH3), 6.56 (s, 4H, 2NH2), 7.38-
7.53 (m, 5H, Ar-H), 7.54 (s, 2H, 2CH); 13C-NMR
(100 MHz, DMSO-d6)δ 160.1, 148.8, 148.1, 136.1, 134.3,
129.6, 128.8, 14.8; MS m/z(%): 426 [M+, 2%]; Anal.
calcd. for C19H14N4S4: C, 53.49; H, 3.31; N, 13.13; S,
30.07 Found: C, 52.64; H, 3.51; N, 13.34; S, 30.32.
4,4'-(3-Methyl-4-phenylthieno[2,3-b]thiophene-2,5-diyl)bis
(1H-imidazol-2-amine) (8c)
8c was prepared from guanidine following GP3 as a
brown powder crystals; Yield (75%); solid, mp > 320°C; IR
(KBr) νmax/ cm
−1: 1624, 3420;1H-NMR (400 MHz,
DMSO-d6)δ 1.87 (s, 3H, CH3), 6.74 (s, 4H, 2NH2), 7.38-
7.53 (m, 5H, Ar-H), 7.51 (s, 2H, 2CH), 12.31 (s, 2H, 2NH);
13C-NMR (100 MHz, DMSO-d6)δ 158.4, 148.8, 148.1,
136.0, 134.3, 129.5, 128.8, 14.8; MS m/z(%): 392[M+, 2%];
Anal. calcd. for C19H16N6S2: C, 58.14; H, 4.11; N, 21.41; S,
16.34; Found: C, 57.64; H, 4.21; N, 21.31; S, 16.29.
General procedure for the synthesis of compounds 9a,b (GP4)
A mixture of compound 2 (236 mg, 0.5 mmol) and anil-
ine derivatives (2 equiv., 1 mmol) in EtOH (15 mL) was
refluxed for 6–8 h in the presence of 0.5 mL of (TEA).
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9a was prepared from aniline following GP4 as a pale
green powder crystals; Yield (90%); solid, mp > 320°C; IR
(KBr) νmax/ cm
−1: 1651, 3385; 1H-NMR (400 MHz,
DMSO-d6)δ 2.02 (s, 3H, CH3), 4.42 (s, 4H, 2CH2), 6.22-
7.57 (m, 15H, Ar-H), 7.61 (s, 2H, 2NH); 13C-NMR
(100 MHz, DMSO-d6)δ 181.0, 147.5, 134.2, 129.7, 129.6,
129.1, 129.0, 120.0, 114.4, 113.9,67.9, 14.8; MS m/z(%):
496[M+, 3%]; Anal. calcd. for C29H24N2O2S2: C, 70.13;
H, 4.87; N, 5.64; O, 6.44; S, 12.91; Found: C, 71.23; H,
4.37; N, 5.34; S, 12.96.
1,1'-(3-Methyl-4-phenylthieno[2,3-b]thiophene-2,5-diyl)bis
(2-(4-chlorophenylamino) ethanone) (9b)
9b was prepared from p-chloroaniline following GP4 as a
pale brown powder crystals; Yield (89%); solid, mp > 320°C:
IR (KBr) νmax/ cm
−1:1651, 3387;1H-NMR (400 MHz,
DMSO-d6)δ 2.03 (s, 3H, CH3), 4.41 (s, 4H, 2CH2), 6.23-
7.58 (m, 13H, Ar-H), 7.63 (s, 2H, 2NH); 13C-NMR
(100 MHz, DMSO-d6)(ppm): 181.1, 147.5, 134.2, 129.7,
129.6, 129.1, 129.0, 120.0, 114.4, 113.9, 67.8, 14.8; MS m/z
(%): 565[M+, 2%]; Anal. calcd. for C29H22Cl2N2O2S2: C,
61.59; H, 3.92; N, 4.95; S, 11.34; Found: C, 60.79; H, 3.87;
N, 4.90; S, 12.24.
Biological activities
Various In vitro assays were performed to the assessment of
biological activity of newly synthesized compounds. Results
were presented here as means ± standard error from tripli-
cate (n = 3) observation. IC50 values were calculated by using
EZ-FIT, Enzyme kinetics software by Perrella Scientific.
Anticancer activity
Cytotoxic activity of compounds was evaluated in 96-
well flat-bottomed microplates by using the standard MTT
(3-[4, 5-dimethylthiazole-2-yl]-2, 5-diphenyl-tetrazolium
bromide, MP) colorimetric assay [39]. For this purpose,
PC3 cells (Prostrate Cancer) were cultured in Dulbecco’s
Modified Eagle Medium, supplemented with 10% of fetal
bovine serum (FBS, PAA), 100 IU/mL of penicillin and
100 μ g/mL of streptomycin in 75 cm2 flasks, and kept in
5% CO2 incubator at 37°C. Exponentially growing cells
were harvested, counted with haemocytometer and diluted
with a particular medium with 5% FBS. Cell culture with
the concentration of 1x105 cells/mL was prepared and in-
troduced (100 μL/well) into 96-well plates. After overnight
incubation, medium was removed and 200 μL of fresh
medium was added with different concentrations of com-
pounds (1-30 μM). Stock solution, 20 mM of compounds
were prepared in 100% DMSO and final concentration ofDMSO at 30 μM is 0.15% .After 48 hrs, 200 μL MTT
(0.5 mg/mL) was added to each well and incubated further
for 4 hrs. Subsequently, 100 μL of DMSO was added to
each well. The extent of MTT reduction to formazan
within cells was calculated by measuring the absorbance at
570 nm, using a micro plate reader (Spectra Max plus, Mo-
lecular Devices, CA, USA). The cytotoxicity was recorded
as concentration causing 50% growth inhibition (IC50) for
PC3 cells. The percent inhibition was calculated by using
the following formula:
% inhibition = 100-((mean of O.D of test compound –
mean of O.D of negative control)/ (mean of O.D of posi-
tive control – mean of O.D of negative control)*100).
The results (% inhibition) were processed by using
Soft- Max Pro software (Molecular Device, USA).
In vitro antioxidant activity
Test samples were allowed to react with stable free rad-
ical, 1, 1-diphenyl-2-picrylhydrazyl radical (DPPH, Wako
Chemicals USA, Inc.)) for half an hour at 37°C. Various
concentrations of test samples (prepared in DMSO)
were incubated with DPPH (300 μM; prepared in etha-
nol). After incubation, decrease in absorption was mea-
sured at 515 nm using a microplate reader (SpectraMax
plus 384). Percentage radical scavenging activity (% RSA)
by samples was determined, in comparison with a
DMSO- treated control group.% Radical scavenging ac-
tivity was calculated by using the formula given in statis-
tical analysis section [40].
In vitro β-glucuronidase inhibition assay
β-Glucuronidase inhibitory activity was determined by the
spectrophotometric method by measuring the absorbance
at 405 nm of p-nitrophenol formed from the substrate
(p-nitrophenyl-β-D-glucuronide N1627-250 mg (Sigma
Aldrich). The total reaction volume was 250 μL. The
compound (5 μL) was dissolved in DMSO (100%), which
becomes 2% in the ultimate assay (250 μL) and the similar
conditions were used for standard (D-saccharic acid
1, 4-lactone, Sigma Aldrich). The reaction mixture
contained 185 μL of 0.1 M acetate buffer, 5 μL of test
compound solution, 10 μL of (1U) enzyme solution
(G7396-25KU, Sigma Aldrich) was incubated at 37°C for
30 min. The plates were read on a multiplate reader
(SpectraMax plus 384) at 405 nm after the addition of
50 μL of 0.4 mM p-nitrophenyl-β-D-glucuronide. All as-
says were performed in triplicate. IC50 Values were calcu-
lated by using EZ-Fit software (Perrella Scientific Inc.,
Amherst, MA, U.S.A.). These values are the mean of three
independent readings [41].
In vitro α-glucosidase inhibition assay
α-Glucosidase inhibition assay was performed spectrophoto-
metrically. α-Glucosidase from Saccharomyces cerevisiae
Mabkhot et al. Chemistry Central Journal 2013, 7:112 Page 8 of 9
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buffer (pH 6.8., 50 mM). Test compounds were dissolved in
70% DMSO. In 96-well plates, 20 μL of test sample, 20 μL
of enzyme and 135 μL of buffer were added and incubated
for 15 minutes at 37°C. After incubation, 25 μL of
p-nitrophenyl- α -D-glucopyranoside (0.7 mM, Sigma Al-
drich) was added and change in absorbance was monitored
for 30 minutes at 400 nm. Test compound was replaced by
DMSO (7.5% final) as control. Acarbose (Acarbose, Sigma
Aldrich) was used as a standard inhibitor [42].
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